TY  - GEN
AU  - Mell,Loren K
AU  - Sirák,Igor
AU  - Wei,Lichun
AU  - Tarnawski,Rafal
AU  - Mahantshetty,Umesh
AU  - Yashar,Catheryn M
AU  - McHale,Michael T
AU  - Xu,Ronghui
AU  - Honerkamp-Smith,Gordon
AU  - Carmona,Ruben
AU  - Wright,Mary
AU  - Williamson,Casey W
AU  - Kasaová,Linda
AU  - Li,Nan
AU  - Kry,Stephen
AU  - Michalski,Jeff
AU  - Bosch,Walter
AU  - Straube,William
AU  - Schwarz,Julie
AU  - Lowenstein,Jessica
AU  - Jiang,Steve B
AU  - Saenz,Cheryl C
AU  - Plaxe,Steve
AU  - Einck,John
AU  - Khorprasert,Chonlakiet
AU  - Koonings,Paul
AU  - Harrison,Terry
AU  - Shi,Mei
AU  - Mundt,A J
TI  - Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
SN  - 1879-355X
PY  - 2017///0714
KW  - Adenocarcinoma
KW  - diagnostic imaging
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bone Marrow
KW  - Brachytherapy
KW  - methods
KW  - Carcinoma, Squamous Cell
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - Feasibility Studies
KW  - Female
KW  - Gastrointestinal Tract
KW  - radiation effects
KW  - Humans
KW  - Incidence
KW  - Middle Aged
KW  - Neutropenia
KW  - epidemiology
KW  - Organ Sparing Treatments
KW  - Radiation-Sensitizing Agents
KW  - Radiotherapy Dosage
KW  - Radiotherapy, Image-Guided
KW  - Radiotherapy, Intensity-Modulated
KW  - Uterine Cervical Neoplasms
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.ijrobp.2016.11.027
ER  -